|
Volumn 283, Issue 13, 2000, Pages 1679-
|
From the Food and Drug Administration.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIINFECTIVE AGENT;
ENZYME INHIBITOR;
OFLOXACIN;
ARTICLE;
COMMUNICABLE DISEASE;
DRUG EFFECT;
DRUG INTERACTION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERICUM;
LOBAR PNEUMONIA;
MEDICINAL PLANT;
PENICILLIN RESISTANCE;
STREPTOCOCCUS PNEUMONIAE;
UNITED STATES;
ANTI-HIV AGENTS;
ANTI-INFECTIVE AGENTS;
COMMUNITY-ACQUIRED INFECTIONS;
DRUG INTERACTIONS;
ENZYME INHIBITORS;
HUMANS;
HYPERICUM;
OFLOXACIN;
PENICILLIN RESISTANCE;
PLANTS, MEDICINAL;
PNEUMONIA, PNEUMOCOCCAL;
STREPTOCOCCUS PNEUMONIAE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0242459281
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|